LuSeed Vascular

Company Overview

Snapshot

Founded in October 2017 by Nitzan Hirsh and Amir Arthur, LuSeed Vascular operates with 11–50 employees. The company has raised $6.5M across three funding rounds from four investors. In January 2023, Gandyr Investments participated in an A Round funding for the company.

Business overview

LuSeed Vascular is a medical technology startup focused on neurovascular innovation within the Health Tech & Life Sciences sector. The company develops the LuSeed ARC, a minimally invasive device designed for treating both bifurcation and sidewall brain aneurysms. This technology aims to provide a standardized method of care that is compatible with robotic systems, serving neuro radiologists and improving patient outcomes while optimizing hospital operations. LuSeed Vascular operates in the Medical Devices, Medical Treatment & Therapeutics, and Implants categories, targeting healthcare providers and the medical products industry in North America, Asia, and Europe.

Strategic signal

In December 2022, LuSeed Vascular appointed Robert Stern to its Board of Directors, signaling a strategic move to strengthen its leadership and governance as the company progresses through its clinical phase. This appointment suggests an emphasis on experienced guidance to navigate the medical device market and clinical development, which is crucial for investor confidence and future market penetration.

Company Intelligence Q&A

When was LuSeed Vascular founded and by whom?

LuSeed Vascular was founded in October 2017 by Nitzan Hirsh and Amir Arthur.

What is LuSeed Vascular's primary product?

LuSeed Vascular's primary product is the LuSeed ARC, a minimally invasive device for treating bifurcation and sidewall brain aneurysms.

What was a key development for LuSeed Vascular in December 2022?

In December 2022, LuSeed Vascular appointed Robert Stern to its Board of Directors, enhancing its leadership as it advances its neurovascular innovations.

Which investor participated in LuSeed Vascular's A Round funding?

In January 2023, Gandyr Investments participated in an A Round funding for LuSeed Vascular.

What was a notable recognition for LuSeed Vascular in November 2018?

In November 2018, LuSeed Vascular was announced as a winner of a healthcare startup competition by Sanara Ventures.